Brought to you by 
Osteotech raises $8M in IPO for use in R&D and marketing
04 Jun 1999
Executive Summary
Osteotech (aseptic processor of bone, ligaments and tendons for transplantation) completed its initial public offering of 1.25 million shares of common stock priced at $7.50 per share, raising $8 million in net proceeds.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Osteotech raises $8M in IPO for use in R&D and marketing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice